Management of Febrile Neutropenia in Cancer Patients

Displaying 1 - 9 of 9CSV
Madarang, E., Lykon, J., Zhao, W., Sekeres, M. A., Bradley, T., Chandhok, N. S., Taylor, J., Venugopal, S., Koru-Sengul, T., Iyer, S. G., Gilbert, J. S., Miller, R. M., Nanni, J., Zacheo, I., Mattei, A., Al Ali, N., Kishtagari, A., Marconi, G., Sallman, D. A., … Watts, J. (2024). Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia. Blood Neoplasia, 1(2), 100016. https://doi.org/10.1016/j.bneo.2024.100016
Publication Date
Dupuis, L. L., Fisher, B. T., Sugalski, A. J., Grimes, A. C., Nuño, M., Ramakrishnan, S., Beauchemin, M. P., Robinson, P. D., Santesso, N., Walsh, A., Wrightson, A. R., Yu, L., Parsons, S. K., & Sung, L. (2024). Clinical practice guideline‐inconsistent management of fever and neutropenia in pediatric oncology: A Children’s Oncology Group study. Pediatric Blood & Cancer, 71(4). Portico. https://doi.org/10.1002/pbc.30880
Publication Date
Columbia Affiliation
Gao, Z., Wei, K., Chen, R., Ye, W., Li, T., Su, Q., Wang, R., & Cao, W. (2024). Retrospective computed tomography assessment of chemotherapy-related pneumonia with severity screening in pediatric acute lymphoblastic leukemia by radiological imaging. Heliyon, 10(1), e23444. https://doi.org/10.1016/j.heliyon.2023.e23444
Publication Date
Dong, S. W., Sharma, T. S., & Sue, P. K. (2023). Approach to multidrug resistant infections in pediatric transplant recipients. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1270564
Publication Date
McNerney, K. O., Fabrizio, V. A., Talleur, A. C., Si Lim, S., Dreyzin, A., Baggott, C., Vatsayan, A., Rossoff, J., Prabhu, S., Pacenta, H. L., Phillips, C. L., Talano, J.-A., Moskop, A., Verneris, M. R., Myers, D., Karras, N., Bonifant, C. L., Qayed, M., Hermiston, M. L., … Naik, S. (2023). Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia. Blood, 142(Supplement 1), 2133–2133. https://doi.org/10.1182/blood-2023-189921
Publication Date
Lee, S., Mazur, S., Mazur, S., Kodiyanplakkal, R. P., Theodore, D., & Kubin, C. J. (2022). 892. Clinical Impact of Early Antifungal De-escalation (≤ 2 days) based on Rapid Species Identification in Patients with Azole-susceptible Candidemia. Open Forum Infectious Diseases, 9(Supplement_2). https://doi.org/10.1093/ofid/ofac492.737
Publication Date
Watabayashi, K. K., Bell-Brown, A., Kreizenbeck, K., Egan, K., Lyman, G. H., Hershman, D. L., Arnold, K. B., Bansal, A., Barlow, W. E., Sullivan, S. D., & Ramsey, S. D. (2022). Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD. BMC Health Services Research, 22(1). https://doi.org/10.1186/s12913-022-07835-4
Publication Date
Landau, H. J., Orlando, E., Rodriguez, E. S., Applebaum, A., Mitchell, H.-R., Peled, J. U., Khan, N., Funnell, T., Chung, D., Scordo, M., Shah, G. L., LeStrange, N. J., Hambright, K. A., McElrath, C. M., Cazeau, N., Devlin, S. M., Perales, M.-A., van den Brink, M. R. M., & Giralt, S. A. (2022). Pilot Trial of Homebound Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(12), 832.e1-832.e7. https://doi.org/10.1016/j.jtct.2022.09.014
Publication Date
Bansal, R., Park, H., Taborda, C. C., Gordillo, C., Mapara, M. Y., Assal, A., Uhlemann, A.-C., & Reshef, R. (2022). Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 28(3), 135–144. https://doi.org/10.1016/j.jtct.2021.12.015
Publication Date